The Infrared Thermometer Market is expected to grow from USD 870.870 million in 2025 to USD 1,274.279 million in 2030, at a CAGR of 7.91%.
An infrared thermometer is a type of thermometer that infers temperature from thermal radiation and permits temperature measurement from a distance without contact with the object. The rising demand for speedy and secure results is expected to drive the growth of the market during the forecast period. Besides, the affordability and simplicity of the usage of the infrared thermometer are also boosting the market. However, the availability of substitutes at lower prices is anticipated to hinder the growth of the market in the coming years.
The rising prevalence of chronic infections around the globe is expected to drive the growth of the market during the forecast period. Also, the prevalence of infectious diseases such as tuberculosis, influenza, and hepatitis A and B is increasing day by day, which is leading to a gradual shift in preference from normal thermometers to infrared thermometers.
It is considered one of the prime drivers for the growth of the market during the forecast period. Both public and private players are investing heavily in developing countries to meet the growing demand for infrared thermometers as health awareness grows.
The growing geriatric population in many parts of the world is expected to be one of the prime drivers for the growth of the market over the forecast period. Also, according to the OECD report, Japan’s aging population will continue to exert pressure on public spending on health, which is the sixth-highest among OECD countries, and spending on long-term care, which has surged drastically in the last decade. Such an increase in spending by both public and private players further propels the growth opportunities of technologically advanced infrared thermometer manufacturers and vendors in the coming years.
By geography, the infrared thermometer market is segmented into North America, South America, Europe, the Middle East and Africa, and the Asia Pacific. Simultaneously, the region is the home of the world’s largest pharmaceutical companies, and with increasing investment by both public and private players; the market is anticipated to witness substantial growth in the region. The North American region is witnessing similar opportunities and is expected to grow at a significant rate over the forecast period. The Asia Pacific is also anticipated to provide good growth opportunities on account of growing health awareness coupled with increasing government support and with the increasing prevalence of chronic infectious diseases in developing countries like China and India, the market in the region will be witnessing exponential growth.
Segmentation: